Myriad’s Alarming Alzheimer’s Forecasts
Myriad Genetics, Inc. (MYGN-NASDAQ) has issued a press release discussing a new study showing that the potential savings to the US healthcare system alone could be $4.0 Trillion from 2010 to 2050. It estimates…